Literature DB >> 22940379

A review of the effect of immunization programs on antimicrobial utilization.

Kyle J Wilby1, Denise Werry.   

Abstract

The objective of this review is to summarize and evaluate the literature pertaining to antimicrobial utilization with respect to implementation of immunization programs or within clinical studies assessing vaccine effectiveness. A literature search was performed using the search terms vaccine; immunization; antimicrobial; antibiotic; influenza; pneumococcal; haemophilus; meningococcal in MEDLINE (1948-May 2012), EMBASE (1980-May 2012), International Pharmaceutical Abstracts (1970-May 2012), Google, and Google Scholar. Identified clinical or epidemiological studies were included if antimicrobial utilization was listed as a reported outcome. Seven articles (three randomized controlled trials and four epidemiological studies) were identified and included in the review. These studies reported outcomes associated with pneumococcal and influenza immunization programs. All studies reported decreased antibiotic use associated with initiation of immunization programs or increased uptake of available vaccines. Large-scale epidemiological studies confirm population-wide decreases observed from short-term randomized controlled trials. Antibiotic reductions ranged from 5 to 10% in randomized controlled trials to relative reductions of 64% in epidemiological studies. These findings suggest that immunization programs may reduce antibiotic utilization. As such, vaccination status queries and updates should become part of routine care for both hospitalized and non-hospitalized patients. Immunization programs should be considered as part of institution-wide antimicrobial stewardship programs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940379     DOI: 10.1016/j.vaccine.2012.08.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015.

Authors: 
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  Antimicrobial stewardship in daily practice: Managing an important resource.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2014-05       Impact factor: 2.253

3.  Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.

Authors:  Carmen Muñoz-Almagro; Adoracion Navarro-Torne; Roman Pallares
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 4.  Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.

Authors:  Timothy F Murphy
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

5.  Antimicrobial stewardship in daily practice: Managing an important resource.

Authors:  Nicole Le Saux
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

6.  Decrease in antibiotic use, an added benefit of PCVs.

Authors:  Carlos G Grijalva
Journal:  Lancet Infect Dis       Date:  2013-11-26       Impact factor: 25.071

7.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

Review 8.  New opportunities for managing acute and chronic lung infections.

Authors:  William O C M Cookson; Michael J Cox; Miriam F Moffatt
Journal:  Nat Rev Microbiol       Date:  2017-10-24       Impact factor: 60.633

Review 9.  Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis.

Authors:  Li Min Wang; Tiago Cravo Oliveira Hashiguchi; Michele Cecchini
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31

10.  The intangible benefits of vaccination - what is the true economic value of vaccination?

Authors:  Paolo Bonanni; Juan José Picazo; Vanessa Rémy
Journal:  J Mark Access Health Policy       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.